• 

  WHO to decide on Bharat Biotech's Covaxin emergency usage in October

  India | September 30, 2021 14:39 IST

  Bharat Biotech had submitted EOI (Expression of Interest) on April 19 for its vaccine.

• 

  Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials

  India | September 21, 2021 14:54 IST

  Covaxin production would touch 55 million doses in October as against 35 million in September.

• 

  Bharat Biotech's Covaxin to get WHO nod this week, say sources

  India | September 14, 2021 15:45 IST

  ​Bharat Biotech's Covaxin will get approval from the World Health Organisation (WHO) this week, sources told news agency ANI.

• 

  Gujarat: First commercial batch of Covaxin released from Bharat Biotech's new plant

  India | August 29, 2021 13:20 IST

  The govt had earlier this month given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce anti-COVID vaccine Covaxin.

• 

  Covaxin single-dose to Covid infected equivalent to 2 doses for unaffected: ICMR

  India | August 28, 2021 14:39 IST

  The ICMR in its recent study has found that the people already infected with Covid-19 while taking a dose of Covaxin have the same or increased antibody response as unaffected people taking two doses of Covaxin.

• 

  India has done better than any country across world in vaccination: Bharat Biotech CMD Krishna Ella

  India | August 15, 2021 14:53 IST

  In his Independence Day speech from the ramparts of the Red Fort, PM Modi said India takes pride in having the world's largest vaccination programme, and over 54 crore people have already taken the COVID vaccines.

• 

  First Covid nasal vaccine by Bharat Biotech gets regulators nod for phase 2, 3 trials

  India | August 13, 2021 18:49 IST

  The first nasal vaccine against coronavirus developed by Bharat Biotech supported by Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance Council (BIRAC) has been given regulator's nod for conducting phase 2 and 3 trials, the Ministry of Science & Technology informed on Friday.

• 

  Covaxin production to get boost as govt approves manufacturing facility in Gujarat's Ankleshwar

  India | August 10, 2021 12:44 IST

  The Centre has approved a vaccine manufacturing facility for the production of Covaxin in Gujarat's Ankleshwar.

• 

  No compromise on Covaxin quality, says Bharat Biotech

  India | August 05, 2021 23:47 IST

  The vaccine maker stated that as of date, all batches of Covaxin were manufactured and released from its manufacturing facilities at Genome Valley, Hyderabad, which are fully audited and approved by regulatory authorities.  

• 

  Covaxin receives GMP certificate from Hungary, says Bharat Biotech

  India | August 05, 2021 10:26 IST

  The approval received is from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin, a note posted on twitter said.

• 

  Bharat Biotech's Rotavac 5D receives WHO Prequalification

  India | August 02, 2021 17:36 IST

  WHO Prequalification enables the procurement of Rotavac 5D by agencies such as UNICEF and PAHO (Pan American Health Organisation) and will fast-track global access to this life saving vaccine.

Advertisement
• 

  Covaxin effective against Delta Plus variant of Covid-19: ICMR Study

  India | August 02, 2021 13:36 IST

  ICMR reveals that Covaxin is effective against the Delta Plus variant of COVID 19.

• 

  WHO commences emergency use listing review process of Covaxin: Govt

  India | July 27, 2021 23:30 IST

  Responding to a question on whether it has come to the notice of the government that Covaxin used in India is not recognised by many countries, Pawar said the government is aware that Covaxin at present is not part of WHO Emergency Use Listing (EUL).

• 

  'Very low' Covaxin stock, meagre supply of doses likely to hit inoculation: Bengal official

  India | July 25, 2021 6:26 IST

  West Bengal has vaccinated over 2.75 crore people so far and out of them, 81.9 lakh got the second dose, the health official said.

• 

  Covaxin trials for children underway; results by Sept: AIIMS chief

  India | July 24, 2021 13:11 IST

  The Government of India has been holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer, for procuring their vaccine. However, there has been a delay over the same.

• 

  CLAT 2021 exam analysis: 'Paper was moderately difficult'; check candidates, experts' reactions

  Education | July 23, 2021 22:02 IST

  The candidates found the Quantitative and Logical reasoning section a bit difficult, while sections like English, GK and Current Affairs were appeared to be easy.

• 

  Bharat Biotech terminates agreement with Brazilian partners after graft allegations

  India | July 23, 2021 23:47 IST

  The termination of the MoU came after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

• 

  AIIMS Delhi to begin Covaxin second dose trial on 2-6 age group next week

  India | July 23, 2021 8:34 IST

  Trials for coronavirus vaccine for children are underway in the country ahead of an anticipated third wave of the pandemic.

• 

  Bharat Biotech partner Ocugen seeks approval for Covaxin in Canada

  India | July 16, 2021 10:51 IST

  The rolling submission process was recommended and accepted under the Minister of Health's Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

• 

  Dip in average daily vaccination against COVID-19 since June 21: Govt data

  India | July 12, 2021 13:55 IST

  A decline in average daily vaccination against the coronavirus has been seen since June 21, when the new phase of universalisation of COVID-19 vaccination commenced, government data showed.